Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-21

Clinical Trial Update: Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 trial updating efficacy and safety of GRT9906 tablets vs placebo in primary fibromyalgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GRT9906

Snippet

Sponsor: Grünenthal GmbH | Conditions: Primary Fibromyalgia | Phase 2 | Status: COMPLETED